Both groups were comparable for age of onset, disease duration, gender, mean number of joints per patient, type of joint injected, JIA subtype, laboratory parameters, and concurrent systemic therapy with MTX and anti-TNFα during and after IAJI. Here, TNF is linked to juvenile idiopathic arthritis.